Aibotics Inc.
AIBT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.31M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.31 Million |
|---|---|
| Enterprise Value | $2.25 Million |
| Earnings per Share | $-0.01 |
| Beta | 1.29 |
| Outstanding Shares | 668,332,522 |
Return
| Return on Equity | 45.49% |
|---|---|
| Return on Assets | -380.88% |
| Return on Invested Capital | -478.33% |
Valuation & Multiples
| P/E Ratio | -0.35 |
|---|---|
| PEG | -3.36 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.22 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | -0.04 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Aibotics Inc.
1 employees
CEO: Benjamin Kaplan
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, a...